Ignite Creation Date:
2025-12-24 @ 6:54 PM
Ignite Modification Date:
2026-05-13 @ 5:20 AM
Study NCT ID:
NCT00226057
Status:
COMPLETED
Last Update Posted:
2020-01-03
First Post:
2005-09-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efalizumab for Moderate to Severe Atopic Dermatitis
Sponsor:
Oregon Health and Science University
Organization: